Zalevsky Jonathan 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Zalevsky Jonathan（CIK 1789857）在 1 家公司共报告 16 笔 SEC Form 4 内部人交易（最近一笔 2026-08-20）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-20 | NEKTAR THERAPEUTICS (NKTR) | Chief R&D Officer | 卖出 | 186 | $13,388 |
| 2026-07-02 | NEKTAR THERAPEUTICS (NKTR) | Chief R&D Officer | 卖出 | 5,681 | $397,670 |
| 2026-06-17 | NEKTAR THERAPEUTICS (NKTR) | Chief R&D Officer | 卖出 | 5,538 | $336,212 |
| 2026-05-21 | NEKTAR THERAPEUTICS (NKTR) | Chief R&D Officer | 卖出 | 199 | $13,036 |
| 2026-02-20 | NEKTAR THERAPEUTICS (NKTR) | Chief R&D Officer | 卖出 | 180 | $13,140 |
| 2026-01-22 | NEKTAR THERAPEUTICS (NKTR) | Chief R&D Officer | 卖出 | 3,867 | $137,936 |
| 2025-12-23 | NEKTAR THERAPEUTICS (NKTR) | Chief R&D Officer | 买入 | 6,250 | $0 |
| 2025-11-25 | NEKTAR THERAPEUTICS (NKTR) | Chief R&D Officer | 买入 | 2,666 | $0 |
| 2025-11-25 | NEKTAR THERAPEUTICS (NKTR) | Chief R&D Officer | 卖出 | 1,157 | $62,802 |
| 2025-09-08 | NEKTAR THERAPEUTICS (NKTR) | Chief R&D Officer | 卖出 | 793 | $25,717 |
| 2025-09-08 | NEKTAR THERAPEUTICS (NKTR) | Chief R&D Officer | 卖出 | 432 | $14,515 |
| 2025-09-08 | NEKTAR THERAPEUTICS (NKTR) | Chief R&D Officer | 卖出 | 189 | $6,503 |
| 2025-09-08 | NEKTAR THERAPEUTICS (NKTR) | Chief R&D Officer | 卖出 | 307 | $10,957 |
| 2025-09-04 | NEKTAR THERAPEUTICS (NKTR) | Chief R&D Officer | 卖出 | 485 | $14,598 |
| 2025-08-21 | NEKTAR THERAPEUTICS (NKTR) | Chief R&D Officer | 卖出 | 725 | $19,278 |
| 2025-05-21 | NEKTAR THERAPEUTICS (NKTR) | Chief R&D Officer | 卖出 | 10,712 | $7,177 |
来源：SEC Form 4 申报文件 · 截至 2026-08-20